ZETIAŽ with Fenofibrate Provided Complementary Lipid Lowering Efficacy in Mixed Hyperlipidemia Patients

home   >   blogdigger

Ezetimibe and Fenofibrate Treatment Well-Tolerated Over 12 Weeks - Results from a new study showed that coadministration of ZETIAŽ (ezetimibe) and fenofibrate significantly reduced LDL ("bad") cholesterol (LDL-C), non-high density lipoprotein cholesterol (non-HDL-C) and apo B1 in patients with mixed hyperlipidemia and high LDL cholesterol when compared to fenofibrate alone... click link for more info.

- link to ZETIAŽ with Fenofibrate Provided Complementary Lipid Lowering Efficacy in Mixed Hyperlipidemia Patients -
Last update: 05/26/2005

Recommended Reading

    Eckerd robbed of OxyContin.(B SECTION) : An article from: Sarasota Herald Tribune
    Atypical Antipsychotics for Treating Depression.(Zyprexa, Risperdal, Seroquel, and Zeldox) : An article from: Behavioral Health Management
    Prozac and the New Antidepressants: What You Need to Know About Prozac, Zoloft, Paxil, Luvox, Wellbutrin, Effexor, Serzone, Vestra, Celexa, St. John's Wort, and Others
    Evidence-based psychiatric medicine: gabapentin and bipolar disorder.(Adult Psychiatry) : An article from: Clinical Psychiatry News
    Montelukast indicated for seasonal allergic rhinitis. (New FDA-Approved Indication). : An article from: Internal Medicine News
    Drug update: Anemia. : An article from: Family Practice News
    Inhalants still 'drug of choice' for ages 8-12, despite decline in use. (More Abused than Ecstasy or Oxycontin). : An article from: Pediatric News
    Eckerd robbed of OxyContin.(B SECTION) : An article from: Sarasota Herald Tribune